LOOP GENOMICS
Live / Applied — Fourth extension granted (statement of use) (as of 02 Feb 2026)
What this means for you
Not registered yet, but its 29 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97696609
- Mark type
- Stylized text
- Filed
- 29 Nov 2022
- Published for opposition
- 12 Dec 2023
- Attorney of record
- Samantha C. Markley
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for basic scientific research and for pharmaceutical, industrial, and medical research purposes
- Class 005 — Pharmaceuticals: Reagents for medical or veterinary purposes; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for medical diagnostic purposes
- Class 042 — Scientific and technological services: DNA and RNA analysis services for scientific research purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for scientific and medical research purposes; software as a service services, namely, providing temporary use of non-downloadable software for bioinformatic analysis of sequencing data
- Class 044 — Medical, beauty and agricultural services: DNA and RNA analysis services for medical diagnostic purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application-specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for medical diagnostic purposes
Owner
- Element Biosciences, Inc., San Diego, CA, US
- Element Biosciences, Inc., San Diego, CA, US
Prosecution history
- 03 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2026 — SOU EXTENSION 4 GRANTED
- 02 Feb 2026 — SOU EXTENSION 4 FILED
- 02 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2025 — SOU EXTENSION 3 GRANTED
- 04 Aug 2025 — SOU EXTENSION 3 FILED
- 04 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2025 — SOU EXTENSION 2 GRANTED
- 21 Jan 2025 — SOU EXTENSION 2 FILED
- 21 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jul 2024 — SOU EXTENSION 1 GRANTED
- 01 Jul 2024 — SOU EXTENSION 1 FILED